ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 615291 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 615291; 2) Community: the network communities that were significantly associated with the response to NSC 615291; 3) Molecule: the relationships between components within communities and NSC 615291; 4) MDR: the compounds that were significantly associated with the NSC 615291.

NSC Compound Enrichment Correlation
NSC 755295 2-(1-(3-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.0109518131763546 0.11703045
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.011234153078014 0.16813316
NSC 702129 Null 0.0112341530780141 -0.086596068
NSC 709928 Null 0.0112341530780141 -0.09547668
NSC 740275 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0112341530780141 0.16105537
NSC 673104 Null 0.01142544011792 0.1401287
NSC 681750 Null 0.01142544011792 -0.14523278
NSC 68093 Null 0.0114553853234973 0.043668704
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0114553853234976 0.56454154
NSC 175630 Toyocamycin, 6-amino- 0.0114553853234976 0.13874652
Total:48  Current:11    [First] [Prev] [Next] [Last]